Bex2, Bex4, and Fibulin have been implicated in the progression of various types of cancer—including breast cancer, glioma, and prostate cancer [57–60]—and work with cell lines and primary tumour samples has provided evidence that epigenetic mechanisms contribute to the regulation of these genes. This evidence concerns the gene BEX2 and neoplasm.